MME and cardiovascular disorder: Although neprilysin seems to be involved in tumor biology as well as in cardiovascular diseases, no association was observed between neprilysin levels and overall survival (p = 0.887) except for myelodysplastic malignancies (HR 1.27; 95% CI, 1.01–1.61; p = 0.044) (14).